Babczyńska, M. (2025) “Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy”, Quality in Sport, 41, p. 59986. doi: 10.12775/QS.2025.41.59986.